| Symbol | IDXX |
|---|---|
| Name | IDEXX LABORATORIES INC /DE |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | In Vitro & In Vivo Diagnostic Substances |
| Address | ONE IDEXX DRIVE, WESTBROOK, ME 04092-2041 |
| Telephone | 2075560300 |
| Fax | — |
| — | |
| Website | https://www.idexx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000874716 |
| Description | Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States. Additional info from NASDAQ: |
FENNELL GEORGE 🟡 adjusted position in 284 shares (1 derivative) of IDEXX LABORATORIES INC /DE (IDXX) at $566.79 Transaction Date: Jun 01, 2026 | Filing ID: 000114
Read moreNew Form SD - IDEXX LABORATORIES INC /DE <b>Filed:</b> 2026-06-01 <b>AccNo:</b> 0000874716-26-000112 <b>Size:</b> 142 KB
Read moreIDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection
Read more📋 Margaret Anne Szostak (Director) plans to sell 1K shares of IDEXX Laboratories, Inc. (at $553.58 each, total $744K) Filed: May 20, 2026 | ID: 000299
Read moreIDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles
Read more(99% Neutral) IDEXX LABORATORIES INC /DE (IDXX) Announces Regulatory Update
Read moreDirector Vandebroek Sophie V. 🟢 acquired 759 shares (2 derivative) of IDEXX LABORATORIES INC /DE (IDXX) at $533.92 Transaction Date: May 12, 2026 | Filing ID: 000107
Read moreDirector SAMAD SAM 🟢 acquired 759 shares (2 derivative) of IDEXX LABORATORIES INC /DE (IDXX) at $533.92 Transaction Date: May 12, 2026 | Filing ID: 000106
Read moreDirector Peacock Karen 🟢 acquired 759 shares (2 derivative) of IDEXX LABORATORIES INC /DE (IDXX) at $533.92 Transaction Date: May 12, 2026 | Filing ID: 000105
Read moreDirector Kingsley Lawrence D 🟢 acquired 1.0K shares (4 derivative) of IDEXX LABORATORIES INC /DE (IDXX) at $533.92 Transaction Date: May 12, 2026 | Filing ID: 000104
Read more